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Background. Tuberculosis contributes significantly to child morbidity and mortality. This study 
aimed to estimate the minimum community based incidence rate of TB among children <3 
years of age in Southern Mozambique.  
Methods. Between October 2011 and October 2012, in the Manhiça District Health and 
Demographic Surveillance System (HDSS) we enrolled prospectively all presumptive TB cases 
younger than under 3 years through passive and active case finding. Participants included all 
children who were either symptomatic or were close contacts of a notified adult smear 
positive pulmonary TB. Children were clinically evaluated at baseline and follow-up visits. 
Investigation for TB disease included chest radiography, HIV and tuberculin skin testing as well 
as gastric aspirate and induced sputum sampling, which were processed for smear, culture, 
and mycobacterial molecular identification.    
Results. During the study period, 13.764 children <3yr contributed to a total of 9.575 person 
years. Out of the 789 presumptive TB cases enrolled, 13 had TB culture confirmation and 32 
were probable TB cases. The minimum community-based incidence rate of TB (confirmed plus 
probable cases) was 470/100.000 person-years (95% CI: 343 to 629/100.000). HIV co- infection 
was present in 44% of the TB cases.   
Conclusion. These data highlight the huge burden of pediatric TB.  This study provides one of 
the first prospective population-based incidence data of childhood tuberculosis and adds 
valuable information to the global effort of producing better estimates, a critical step to inform 
public health policy. 
Abstract
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Introduction 
Tuberculosis (TB) is an under-recognized but potentially important cause of morbidity 
and mortality in children in TB endemic settings1,2. Infants and young children 
(<3years) and those with immunodeficiency caused by HIV or severe malnutrition are 
at highest risk of developing TB disease following infection3. Delay of diagnosis and 
treatment in these children increases the risk of rapid disease progression and 
mortality4. TB diagnosis is particularly challenging in this population, given the lack of 
specific symptoms, the difficulty in obtaining samples for microbiological examination, 
and the often pauci-bacillary disease. The diagnostic yield of samples is often <20% 
under TB program conditions5,6.  These diagnostic difficulties result in delayed and 
under-diagnosis of the disease, contributing to the hidden burden of TB in children. 
 
Child TB is receiving more attention3 as the World Health Organization (WHO) post-
2015 TB strategy seeks to engage the wider health sector including the child health-
care sector7.  The WHO Global Tuberculosis Report 2014 estimates that 550 000 
children developed tuberculosis during 2013, representing 6% of the global TB 
burden8. However, several factors suggest that the true burden of disease may be 
higher as these estimates  assume an equal ratio of notified cases in children and 
adults (whereas under-reporting in children is very common9) , and estimated deaths 
only include those in HIV negative children3. As a setting´s total TB burden increases, 
there tends to be a rise in the proportion of TB cases attributable to children10. Thus, in 
high TB burden settings, children may represent up to 10-20% of TB cases, with 
increased TB incidence in <5years (yr) and >15yr 4,8,11.  
 
Manuscript
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Mozambique is one of the high TB burden countries listed by the WHO but has a very 
low reported case-detection rate of  37%8.  Improved reliable estimates are required  
to quantify the hidden burden of disease and measure future progress towards the 
control of TB in the country, especially for vulnerable populations such as children 
8,12,13.  We therefore aimed to determine the minimum community-based incidence 
rate (IR) of childhood TB.  
 
Materials and Methods 
 
Setting  
The study was conducted in the Manhiça District (rural southern Mozambique), where 
the Manhiça Health Research Center (Centro de Investigação em Saúde de Manhiça, 
CISM) runs a Health and Demographic Surveillance System (HDSS) including the 
Manhiça District Hospital (MDH) and other peripheral health posts in the area. The 
HDSS links demographic and clinical data and covers a population of around  92,000 
inhabitants , of which approximately 11% are <3yr 14.  A full description of the site can 
be found elsewhere14. In 2011, the <5yr mortality rate was 70/1000 live births. Severe 
malnutrition is common with an estimated IR of 35/1000 person-years among children 
from 1-2yr15. 
 
TB treatment is offered free of charge at the health units and children are routinely 
vaccinated at birth with Bacille Calmette-Guérin (BCG), with estimated coverage 
ranging from 86-90% 16,17. The 2013 WHO TB incidence estimates for the country is 
552/100.000 population8. The HIV prevalence in the district is among the highest in the 
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world, reaching 39.9% in the community among individuals aged 18-47 yr and 29.4% 
for women attending the antenatal clinic18.   
 
Study Design and participants 
A prospective study was designed to recruit participants through passive and active 
case finding in the community, MDH and peripheral health centers during a 1yr period 
(2011-2012). Participants included all children from the HDSS who were <3yr at the 
time of enrolment and had either TB symptoms or were close contacts of a notified 
adult smear positive pulmonary TB case (PTB). Relapse or recurrent cases were 
excluded.  
 
Clinical Procedures 
Presumptive TB cases were identified through two strategies: A) Passive case detection 
of children presenting to the health facility with ≥1 symptoms compatible with TB (see 
Table 1 for a complete list of symptoms). Those not recruited at the time of the visit to 
the clinic were later identified through the clinical data collected at the health unit by 
the HDSS. B) Active case finding consisted of linking the adult smear positive PTB cases 
registered at the district National TB Program (NTP) in the previous 24 months to the 
HDSS database in order to identify all household contacts <3yr.  At enrolment, 
demographic and clinical information was collected through interviewing of parents 
and physical examination. Participants had a chest radiography (CXR) performed, 
followed by HIV antibody testing and tuberculin skin testing (TST). CXR were 
performed with a digital X-ray machine and included posteroanterior and lateral 
projections. For clinical purposes, an initial reading was performed on site by the 
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clinician. Subsequently, all CXR were reviewed and re-assessed by an experienced 
pediatric radiologist (JR) who was blinded to the clinical information.  TST was 
performed with intradermal injection of 2 units (Serum Staten´s Institute, Denmark) 
and reading at 48-96h, according to the study protocol. For symptomatic cases, in the 
same day 2 ambulatory samples were obtained in a negative pressure facility available 
at the MDH: one gastric aspirate (GA) and one induced sputum (IS) with 
nasopharyngeal suction, following WHO recommendations19. Asymptomatic cases with 
abnormal CXR did not undergo sampling but were re-evaluated at further visits. For 
suspected extrapulmonary TB (EPTB) appropriate samples were obtained.  
 
All case management was performed by the NTP according to established national 
clinical guidelines. Those patients with clinical or microbiological diagnosis of TB were 
started on TB treatment at the NTP with the standard 3 or 4 first-line regimens 
according to WHO category.  Other symptomatic patients were referred for specific 
treatment and follow-up including antibiotics or nutritional supplementation if 
indicated. Presumptive cases had a follow-up visit within the next six months 
regardless of initial disease classification to assess resolution of symptoms without 
anti-TB treatment and /or clinical response to alternative therapy (if any). If 
persistently symptomatic, further evaluation and testing including CXR and samples 
was performed to rule out TB.  Contacts had a follow-up visit which included physical 
examination and CXR, as well as GA and IS samples for those symptomatic or with an 
abnormal CXR. 
 
Laboratory Procedures 
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Samples were transported within 4 hours of collection and processed in the Biosafety 
Level III TB laboratory at CISM. Following NaCl/NaOH digestion and concentration 
through centrifugation, all samples were processed for acid fast bacilli smear testing 
using LED Microscopy and Zielh Nielsen staining and inoculated into liquid culture 
media (BACTEC MGIT 960® -automated) and solid media (Lowenstein Jensen). Positive 
cultures were confirmed using Zielh Nielsen staining and rapid test as well as Xpert 
MTB/RIF and identified through mycobacterial molecular identification (HAIN 
GenoType® Mycobacterium CM/AS). First line drug sensitivity testing was performed 
either on liquid culture or line probe assays. The laboratory is subject to an external 
quality assurance program. 
 
BOX: Study definitions 
 Exposure to TB was defined as either documented (identified through active case 
finding) or reported contact (household or regular contact during child lifetime). 
 Positive TST was defined as an induration >5mm for HIV or malnourished children 
and >10mm for the rest of participants. 
 HIV infection was defined as: positive antibody test in children>18 months 
(Determine, Abbott Laboratories and confirmed with Unigold, Trinity Biotech); or 
positive HIV PCR in those <18 months; or a strong clinical suspicion with positive 
antibody test in the absence of a PCR result. 
 CXR were classified as compatible if presented ≥1 of the following radiographic 
abnormalities: airway compression, lymphadenopathy, opacification, nodular 
picture, effusion, cavities, spondylitis or Ghon focus20.   
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 Presumptive TB cases included all children <3 with compatible TB sign or 
symptoms.  
 Confirmed TB cases included those with compatible symptoms plus a positive 
culture with Mycobacterium Tuberculosis . Probable TB cases were defined as 
those with:(1) compatible symptoms unresolved at last clinical follow up visit (prior 
to any TB treatment initiation) plus (2) compatible CXR (for children with ≥1CXR, 
the latter was used given the likelihood of seeing resolving pneumonias) plus (3) at 
least one of the following: TB exposure, positive TST or positive response to TB 
treatment. EPTB cases followed the same definition except for the requirement of 
having an abnormal CXR.  The study TB case definition was adapted a standardized 
clinical case definition of intrathoracic TB disease and included confirmed plus 
probable cases 21 (See Figure 2 for complete case definition). 
 
Ethical approval  
The study protocol was approved by the Mozambican National Bioethics Committee 
and the Hospital Clinic of Barcelona Ethics Review Committee. 
 
Data Analysis and Statistical Considerations 
Clinical data was double entered in an electronic data capture system (OpenClinica ™ 
www.openclinica.org) and checked for discrepancies. Statistical software for analysis 
was Stata 13.0 (StataCorp. 2013. Stata: Release 13. Statistical Software. College 
Station, TX: StataCorp LP). We calculated z-scores for weight-for-age, height-for-age 
and weight-for-height using World Health Organization 2006 reference data22 .  
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The minimum community-based IR was calculated as a density rate with the age-
specific yearly number of TB cases (according to the study case definition) among 
study participants divided by the total age-specific population at risk during a period of 
12 months (person-time at risk).  Time at risk was individually measured using DSS data 
taking into account demographic events (births, deaths, migrations) of all children 
included in the study. The IR is considered to be minimum as the case detection 
system cannot ensure that all TB cases are detected.  For each IR 95% exact Poisson 
confidence interval were calculated.  Proportions were compared using the Pearson or 
Fisher exact Chi-square test and odds ratio (OR) and 95% confidence intervals (CI) were 
estimated using logistic regression. Variables at a significance level below 0.2 were 
chosen and placed on stepwise backward multivariate logistic regression. Only factors 
with a p-value on likelihood ratio tested were retained on the model.   
 
Results 
During the study period, 13.764 children <3yr contributed to a total of 9.575py in the 
Manhiça DSS (Figure1). A total of 789 presumptive TB cases were enrolled (42 and 747 
identified through active and passive case finding respectively). Forty-five children 
fulfilled the TB case definition -13 microbiologically confirmed plus 32 probable TB 
(Figure 2). Thus, the minimum community-based IR was 470/100.000person-year 
(95%CI 343/100.000 to 629/100.000) for confirmed plus probable cases and 
135/100.000person year for confirmed cases (95%CI 72 to 232/100.000)(Table 2).   
 
Baseline characteristics of presumptive TB cases are presented in Table 1. Fifty-four 
percent were males, and the age distribution showed a predominance of children 
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between the ages 12 to 24 months (51%). The most frequent clinical feature at 
enrolment was severe malnutrition, which was the only symptom in 72% of cases. 
Nutritional assessment found that almost a quarter had severe undernutrition (weight 
for age Z score <3). Of the 1347 total CXR performed during the study, 27% had only 
one projection. Twenty-one percent of all presumptive TB cases had a CXR compatible 
with TB. Thirty percent of presumptive cases had a second TST of which, 9% had a 
positive TST. Among all presumptive TB cases, nine had a positive smear, although 
none of the 9 had a positive MTBC culture (4 were NTM and 5 were culture negative).  
Non-TB mycobacteria (NTM) were isolated in 27% of all cultures of presumptive cases.  
We found 7 EPTB cases - 4 lymph node and 3 disseminated- and no TB meningeal 
cases. A total of 104 children were diagnosed as HIV positive (13%).      
 
We identified 13 confirmed TB cases (7 in GA, 4 in IS and 2 both in GA and IS).  The % 
of confirmed cases among TB cases was highest for those <1y (40% vs 29 and 22% 
among children with 1-2yr and 2-3yr respectively), and statistically significantly lower 
for HIV-TB co-infected cases (10 vs 44%, p=0.02). Confirmed cases presented a higher 
frequency of cough or fever as compared to probable cases. Furthermore, the 
confirmed cases appeared to be more symptomatic at enrolment than did the 
probable cases (53.8% vs 15.6% presenting with ≥1 TB symptom respectively, 
p<0.001). Probable cases had a higher proportion of HIV-infection (p=0.01), positive 
TST (p=0.001) or BCG scarring (p=0.08) as compared to confirmed cases. 
 
Multivariate logistic regression analysis for TB risk factors showed that HIV infection, 
and number of previous outpatient consultations were predictors of TB disease when 
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compared to unlikely TB cases.  After adjusting for other variables, HIV infected 
children were six times more likely to have TB disease than uninfected ones (OR 8.4, 
95% CI 4 to 17) (Table 3, available online). 
 
Fifty-two patients were started on TB treatment based on clinical or microbiological 
criteria, 67% fulfilled the study TB case definition (Table 4). A total of 97 children 
initiated isoniazide preventive treatment (IPT) (71 based on exposure history, 21 on 
TST results and 5 unspecified) and 5 were later diagnosed as TB cases while on IPT. Due 
to drug supply shortages, isoniazide was not always available and 47 % of children with 
criteria did not initiate IPT.   The mortality rate for all presumptive cases at 12 months 
after enrolment was 5.2% and increased with decreasing age (10.9, 5.7 and 0.8% of 
children in the first, second and third year of life respectively, p<0.001) . Mortality was 
also higher in TB cases as compared to non-TB (13% vs 5% respectively, p=0.02) as it 
was in HIV infected children as compared to HIV-uninfected (14.4% vs 3.8%, p<0.001). 
The case fatality rate was 9% (N=4/45 TB cases), all deaths taking place in the first 6 
months after enrollment. 
 
Discussion 
This study provides one of the first prospective population-based incidence estimates 
of childhood tuberculosis in a high TB-HIV endemic setting and shows a consistently 
high IR across all ages. These results underscore the hypothesis of a gross under-
detection and under-reporting of childhood TB in Mozambique and globally23.  
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Mozambique has almost half its population below the age of <15yr, and yet, pediatric 
TB only accounted for 7% of all new cases notified in 2012, much lower than the 
expected 10-20% of the total burden of TB disease seen in high burden countries.  In 
the Manhiça District, the notified IR for children <1yr and between 1-4 yr in 2011 was 
163 and 399/100.000 respectively (personal communication24). This corresponds to 
half the TB IR reported in this study and may suggest under-detection and under-
diagnosing.  Furthermore, under-detection is common in the wider Mozambican 
context, where WHO estimates that only 37% of actual TB cases are detected8.  While 
the latest WHO country incidence estimates are 552 per 100.000 population, data 
from Manhiça suggest that the burden of disease in Southern Mozambique might be 
much higher. In fact, while the national 2011 notified rate was 186/100.000 
population, same-year data from the Manhiça suggest the TB incidence rate of smear 
positive cases could be as high as 456 per 100,000 population among adults aged 18 to 
47 yr25. 
 
Globally, several pediatric TB incidence estimates have been published recently, with 
results varying from less than 200 000 new cases in 201326 to 970 000 in 20106. The 
large variation in the estimates highlights the challenges in estimating the burden of 
pediatric TB and the need for population-based data to inform predictive models. 
 
There are few studies reporting age-specific pediatric TB incidence in high burden 
countries. Most studies are based on hospital-based retrospective reviews of 
notification rates and, to our knowledge, none have reported community IR using DSS 
11,27–35. However, in areas where health seeking behavior strongly modifies the pattern 
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of attendance, community based studies that use active case detection rather than 
notified TB rates are necessary to provide accurate estimates.  Moreover, childhood 
mortality and frequent migration are potential causes of disease underestimation if 
DSS person-years are not available.  Inconsistency in TB clinical definitions among 
studies are a challenge for comparability and have been a limitation in obtaining data 
for meta-analyses. The recently proposed definition, applied in this study, may pave 
the road for future comparisons9. The IR we report is significantly higher than in other 
high burden African countries such as Malawi (notified IR<1y of 78/100.000) or 
Tanzania (theoretical IR<5y based on likelihood of disease progression of 134.5 to 
308.5/100.000) and similar to data from Gabon (extrapolated IR<15y 366/100.000), or 
neighboring South Africa (notified IR<5y 770/100.000) 30 31 32. 
 
There are several limitations to this study, mostly leading to a possible 
underestimation of the true TB incidence.  First, only single-day samples were obtained 
as most patients would not accept overnight admission, decreasing the chances of 
microbiological confirmation. Second, for study purposes CXR were read by a single 
blinded experienced pediatric radiologist rather than the two independent CXR readers 
are often recommended to prevent bias, given the pivotal role of CXR in case 
definition, and the poor inter and intra-observer agreement among reviewers 36. Third, 
contact tracing could not be fully implemented mainly due to difficulties in patient 
identification and poor recording..  Fourth, the % of EPTB cases was lower than the 20-
30% expected and reported by others11,30,31,37–39. While BCG protection may have a 
role, it is likely that some EPTB cases in this study were missed; the reason may be due 
to a stronger focus on pulmonary TB in the study design, errors in classification 
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(disease localization, including disseminated TB, may be confounding in young children 
in the absence of CT-scan), or lost cases due to the fact that severely ill children are 
often transferred to the tertiary reference hospital in the capital for specific diagnostic 
procedures. Finally, there is a risk of overestimating TB IR by either including TB 
prevalent cases at enrollment or adding new incident cases during follow-up beyond 
the one year enrollment period. Although this possibility can´t be ruled out, we believe 
the effect would be minimal and probably overweighed by the above-mentioned risk 
of underestimation. 
 
In this study, HIV prevalence was high regardless of disease classification, reaching 56% 
of probable cases. The fact that significantly fewer HIV infected children had TB 
confirmation reflects the diagnostic difficulties in this group. Given the overlap 
between symptoms from both TB and HIV, HIV infected cases of TB pose the greatest 
ascertainment bias with the highest risk of over or under estimation. Even though IPT 
is indicated in all HIV positive children, the implementation of IPT among African NTP 
remains very poor40, and in this study, the high proportion of missed opportunities for 
chemoprophylaxis in HIV and or TB exposed should raise alert. There may also be 
missed preventable child deaths in HIV-infected presumptive TB cases and possible TB 
cases. It has been reported that many children who die of diseases such as 
malnutrition or respiratory infections may have in fact, undiagnosed TB41 .There is thus 
a need for widespread recognition that TB control is crucial for childhood survival 1. 
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This study highlights the huge burden of pediatric TB under detection in children under 
3. These data add valuable information to the global effort of producing better 
estimates of childhood TB burden, a critical step to inform public health policy.   
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Table 1.  Baseline characteristics of  presumptive TB cases (n=789), N (%) 
Sex (male) 430 (54,5) 
Age in months (Median [IQR]) 19.8 (13.8-25.9) 
Age group 
 
< 1 yr 146 (18.5) 
1-2 yr 403 (51.1) 
>2 yr 240 (30.4) 
BCG scar (n=785) 686 (87.4) 
> 1 hospitalization in previous year 206 (26.1) 
≥ 10 consultations in previous year 131 (16.6) 
TB contact (documented or reported) 87 (11) 
Symptoms * 
 
Cough ≥2 weeks  156 (19.8) 
Fever≥2 weeks  50 (6.3) 
Malnutrition (chronic or acute) 668 (84.7) 
Wheeze or lower respiratory infection  43 (5.5) 
Adenopathy  3 (0.4) 
Number of presenting symptoms 
 
One symptom 608 (77.1) 
Only malnutrition 565 (71.6) 
Hospitalized at time of enrolment 101 (12.8) 
Physical examination 
 
Stunting (n=775)  † 404 (52.1) 
Undernutrition (n=777) ‡ 184 (23.7) 
Wasting (n=775) ¥ 92 (11.9) 
Kwashiorkor (n= 780) 33 (4.2) 
Febrile (N=780) 44 (5.6) 
Crackles on chest examination  27 (3.4) 
TST positive (n=787) 74 (9.4) 
HIV positive 104 (13.2) 
Radiological changes suggestive of TB (n= 766) 160 (20.9) 
 
Footnote:  
Abbreviations:  IQR, interquartile range; BCG, Bacille Calmette Guerin;  HIV, human 
immunodeficiency virus; TST, tuberculin skin test 
* Compatible TB symptoms: cough for ≥ 14 days not responding to appropriate course of 
antibiotics;  fever greater than 38ºC ≥ 14 days . after common causes like malaria or 
pneumonia were excluded; malnutrition defined as under 60% weight for height, failure to 
gain weight for more than 2 months or any loss of weight and not responded to nutritional 
interventional; unexplained wheeze ≥ 14 days not responding to standard treatments; 
lower respiratory tract infection ≥ 14 days not responding to antibiotics after 72hours; TB 
exposure in the last 12 months; symptoms compatible with extrapulmonary TB (EPTB) 
such as painless enlarged lymph nodes with or without fistula formation ≥ 14 days, 
arthritis, gibbus, meningitis, effusion, or unexplained hematuria, dysuria or polaquiuria for 
≥21 days.   
† Stunting: Height for age Z score <2.  
‡ Undernutrition: Weight for age Z score < 2.  
¥ Wasting: Weight for height <2.  
 
Table
Table 2: Community based incidence rate of confirmed and probable tuberculosis cases by 
age group 
 
All tuberculosis cases 
    
  
Cases PY 
Incidence Rate 
per 100000py 
95% Confidence 
Interval 
Confimed 13 9575,6 135,8 72,3 232,2 
Probable 32 9575,6 334,2 228,6 471,8 
Total 45 9575,6 470,0 342,8 628,8 
 
     
Confirmed cases by age group 
   
Age (years) 
Cases PY 
Incidence Rate 
per 100000py 
95% Confidence 
Interval 
< 1 4 3265,6 122,5 33,3 313,3 
1-2 5 3199,4 156,3 68,9 407,8 
2-+ 4 3110,5 128,6 52,2 374,5 
All Confirmed 13 9575,6 135,8 72,3 232,2 
      Probable cases by age group 
   
Age (years) 
Cases PY 
Incidence Rate 
per 100000py 
95% Confidence 
Interval 
< 1 6 3265,6 183,7 67,4 399,9 
1-2 12 3199,4 375,1 193,8 655,2 
2-+ 14 3110,5 450,1 246,1 755,2 
All Probable 32 9575,6 334,2 228,6 471,8 
      All cases by age group 
    
Age 
Cases PY 
Incidence Rate 
per 100000py 
95% Confidence 
Interval 
< 1 10 3265,6 306,2 146,9 563,2 
1-2 17 3199,4 531,4 309,5 850,7 
2-+ 18 3110,5 578,7 343,0 914,6 
All TB Cases 45 9575,6 470,0 342,8 628,8 
 
 
Footnote:  
Abbreviations:  PY, person years 
Table
Table 3.  TB risk factor analysis  
  
TB Unlikey (N=603) TB Case (N=45) 
Univariate  Adjusted OR (95% CI) 
  OR (95% CI) p OR (95% CI) p 
Sex 
        
Male 322 53,4% 20 44,4% - 
   
Female 281 46.6% 25 55,6% 1.43 (0.78-2.64) 0.246 1.52 (0.79-2.92) 0.210 
Age in months (Median 
[IQR]) 
19.8 (14.1 - 26.0) 19.5 (13.8 - 26.4) 
    
Age category, N (%) 
        
< 1 100 16,6% 10 22,2% - 
   
1-2 318 52,7% 17 37,8% 0.53 (0.24 - 1.21) 
 0.51 (0.21-1.23) 
0.133 
2-+ 185 30,7% 18 40,0% 0.95 (0.43 - 2.19) 0.153 0.94 (0.39-2.26) 0.890 
BCG Scar 
        
Absent 74 12,3% 7 15,6% - 
   
Present 527 87,7% 37 82,2% 0.74 (0.32 - 1.73) 0.488 
  
TB contact 
        
No 557 92,4% 32 71,1% - 
   
Yes 46 7,6% 13 28,9% 4.92 (2.38 - 10.15) < 0.001 
  
Nº consultations in 
previous year         
Median (IQR) 5 (3 - 8) 7 (2 - 11) - 0.074 
  
< 10 505 83,7% 29 64,4% - 
   
10 - + 98 16,3% 16 35,6% 2.84 (1.48 - 5.47) 0.001 2.72 (1.35-5.49) 0.005 
Nº of hospitalizations in 
previous year         
None 446 74,0% 26 57,8% - 
   
At least one 157 26,0% 19 42,2% 2.08 (1.11 - 3.87) 0.019 
  
Symptoms at enrollment 
        
Cough ≥2 weeks 
        
no 489 81,1% 36 80,0% - 
   
yes 114 18,9% 9 20,0% 1.07 (0.50 - 2.29) 0.857 
  
Fever≥2 weeks 
        
no 567 94,0% 40 88,9% - 
   
yes 36 6,0% 5 11,1% 1.97 (0.73 - 5.30) 0.172 
  
Chronic or Acute 
Malnutrition malnutrition         
no 82 13,6% 12 26,7% - 
   
yes 521 86,4% 33 73,3% 0.43 (0.21 - 0.88) 0.016 0.42 (0.19-0.89) 0.024 
Physical Exam 
        
Stunting † 
        
no 281 46,6% 16 35,6% - 
   
yes 312 51,7% 28 62,2% 1.58 (0.83 - 2.98) 0.158 
  
Undernutrition  ‡ 
        
no 460 76,3% 30 66,7% - 
   
yes 134 22,2% 14 31,1% 1.60 (0.82 - 3.11) 0.161 
  
Wasting  ¥ 
        
no 531 88,1% 37 82,2% - 
   
yes 62 10,3% 7 15,6% 1.62 (0.69 - 3.80) 0.262 
  
Table3
Crackles on chest 
examination         
no 584 97,0% 39 90,7% - 
   
yes 18 3,0% 4 9,3% 3.32 (1.07 - 10.36) 0.052* 
  
Tuberculin skin test 
        
Postive 0 0,0% 23 51,1% - 
< 0.001µ   
Negative 603 100,0% 21 46,7% - 
  
HIV Reported 
        
Not positive 549 91,0% 25 55,6% - 
   
Postive 54 9,0% 20 44,4% 8.13 (4.12 - 16.04) < 0.001 8.42(4.26-16.62) < 0.001 
 
 
Footnote:  
Abbreviations:  IQR, interquartile range; BCG, Bacille Calmette Guerin;  HIV, human 
immunodeficiency virus; TST, tuberculin skin test 
† Stunting: Height for age Z score <2.  
‡ Undernutrition: Weight for age Z score < 2. 
¥ Wasting: Weight for height <2  
µ This variable was not included in multivariate analysis as a positive TST is part of the TB 
definition 
* Exact Chi-squared test 
Table 4. Outcome by group classification, N (%) 
 
  Presumptive Definite Probable Possible Unlikely MTB infection 
  (N=789) (N=13) (N=32) (N=96) (N=603) (N=45) 
Sex (male) 430 (54.5%) 5 (38.5%) 15 (46.9%) 57 (59.4) 322 (53.4%) 31 (68.9%) 
HIV positive 104(13.2%) 2 (15.4%) 18 (56.3%) 24 (25%) 54 (9%) 6 (13.3%) 
IPT 64 (8.1%) 1 (7.7%) 4 (12.5%) 4 (4.2%) 24 (4%) 31 (68.9%) 
TB treatment 52 (6.6%) 9 (69.2%) 26 (81.3%) 14 (14.6%) 1 (0.2%) 2 (4.4%) 
Median time to diagnosis 
(days) N (IQR) 
115 (35-224) 41 (35-115) 184 (55-224) 60 (35-235) 14 (14 - 14) 148 (89 - 207) 
Mortality at 12 months 41 (5.2) 3 (23.1%) 1 (3.1%) 13 (13.5%) 23 (3.8%) 1 (2.2%) 
 
 
Footnote:  
Abbreviations: HIV, human immunodeficiency virus; IPT, isoniazide preventive treatment; 
IQR, interquartile range; TST, tuberculin skin test 
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Figure 1. Study Profile  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PASIVE CASE FINDING
Identified children with compatible TB symptoms
N= 1483
Children under 3 years in Manhiça DSS during the study period (October 2011-October 2012)
N= 13764
9575.6 Person–years 
Enrolled contacts
N = 102
Enrolled presumptive TB cases 
further work-up examination 
N=789
≥1 Follow up visit 
N = 697
24- Died
31- Migrations
27- Refused follow-up
9-Other
Presumptive TB
Presumptive TB
437- Not eligible
26-Died
110-Migrations
121- Refused to 
consent
ACTIVE CASE FINDING
DSS children <3y contacts of adult smear 
positive PTB
N = 180
Lost to follow-up
N = 7
Follow-up 
N = 58
16- Died
29- Migrations
13- Refused follow-up
7- Other
YES
N=3
YES
N = 39
NO
N = 56
Notified smear 
positive  PTB
adults belonging 
to DSS 
N = 123
4- Refused to consent
7- Died
7- Migrations
60 – Not identified
Figure
Figure 2. Algorithm for study case classification adapted from Graham et al (JID, 2012). 
 
 
Recruited
[789]
PERSISTENT SYMPTOMS:
Last visit  (prior to  TB Treatment initiation if applicable)
with sympthoms?
ABNOMAL X Ray:
Last XR TB compatible ?
(prior to TB treatment initiation if applicable)
Microbiological Confirmation?
CONFIRMED TB
[13]
Yes
No [776]
No (or not available) [143] 
PROBABLE TB
[30]
POSSIBLE TB
[98]
Documented exposure [9]
OR
Immunologic evidence
of infection with
M. tuberculosis [18]
OR
Response to tratment
 (for those who initiated TB treatment
 and when evaluation possible) [18]
No documented exposure
AND
No immunologic evidence
of infection with
M. tuberculosis
AND
No response to treatment 
(OR response to evaluated)
[35]
TB UNLIKELY
[603]
Resolution of
symptoms without
 antiTB theraphy
AND
Immunologic evidence
of infection with
M. tuberculosis
[45]
No [568] Yes [208]
YES: Consistent with TB [65]
Documented exposure
OR
Immunologic evidence
of infection with
M. tuberculosis
OR
Response to tratment
 (for those who initiated TB treatment 
and when evaluation possible) 
[63]
No documented exposure
AND
No immunologic evidence
of infection with
M. tuberculosis
AND
No response to treatment 
(OR response to evaluated)
[80]
Resolution of
symptoms without
 antiTB theraphy
AND
NO Immunologic evidence
of infection with
M. tuberculosis
[523]
MTB INFECTION
[45]
+ 2 PROBABLE EPTB 
ALL PROBABLE TB
[32]
Figure 1.  Study Profile 
 
Flowchart showing the number of children under three in the study area and those 
enrolled in the study. A total of 1483 children were identified with at least one compatible 
TB symptom and 747 presumptive TB cases were enrolled in the study for further work-
up.    Among the 329 adult smear positive cases registered at the NTP between October 
2010-October 2012, we identified 123 belonging to the study area and 180 contacts <3y, 
of whom 102 accepted to participate in the study yielding an additional 42 presumptive 
TB cases.  Among the remaining 60 contacts, 7 were lost to follow-up and the rest had at 
least one follow up visit.  Eighty-eight percent presumptive TB cases enrolled had at least 
one follow-up visit and 632/697 completed follow-up (had follow-up visits until 
alternative diagnosis was made  or became asymptomatic).   Abbreviations: DSS, 
Demographic Surveillance System; PTB, pulmonary tuberculosis. 
 
Figure 2.  Algorithm for study case classification adapted from Graham et al (JID, 
2012) 
Definitions. Confirmed TB: Compatible symptoms plus a positive culture with MTBC 
Persistent symptoms: Compatible symptoms unresolved at last clinical follow up visit 
(prior to any TB treatment initiation). Consistent CXR: CXR read by blinded experienced 
pediatric radiologist with one or more  radiographic abnormalities (airway compression, 
lymphadenopathy, opacification, nodular picture, effusion, cavities, spondylitis or Ghon 
focus). For children with more than one CXR, the latter was used given the likelihood of 
seeing resolving pneumonias. Positive response to TB treatment:  determined by the 
clinician at first possible follow-up visit and defined as  total/partial resolution of clinical 
features suggestive of TB present at baseline with no new clinical features suggestive of 
TB for those patients adherent to TB treatment.  Resolution of symptoms without anti-TB 
treatment was evaluated by the clinical at first follow-up visit as total/partial resolution of 
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clinical symptoms suggestive of TB present at baseline and no new clinical features 
suggestive of TB in the absence of TB treatment.  
Description:  Of the initial 789 presumptive TB cases, 568 had symptoms resolved at 
follow-up visits, leaving 208  presumptive cases with  persistent TB symptoms, of which 
65 had an abnormal CXR at last visit. Probable cases include 30 children who fulfilled the 
definition plus an additional 2 extrapulmonary-cases.  Contacts not enrolled as 
presumptive TB cases are not included in the algorithm. 
 
 
